The clinical value of fasting blood glucose,glycosylated hemoglobin and high-sensitivity C-reactive protein in acute phase of cerebral infarction / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 1844-1845, 2008.
Article
en Zh
| WPRIM
| ID: wpr-396780
Biblioteca responsable:
WPRO
ABSTRACT
Objective To discuss the clinical value of combined determination of fasting blood glucose (FBG),glycosylated hemoglobin(HbA1c)and high-sensitivity C-reactive protein (hs-CRP)in patients with acute cerebral infarction.Methods 105 patients with acute cerebral infarction were scored using the standard of Europ Stroke Score(ESS) ,and the level of FBG,HbA1c and hs-CRP were measured.All the patients were divided into three groups,according to the level of FBG and HbA1c,and the index of three groups were compared.Results The hyperglycemic group without diabetes had lower ESS score than the group with normal blood glucose(P <0.01 )and the group with hyperglycemia and diabetes(P <0.05).Also the hyperglycemic group without diabetes had higher level of hs-CRP than the group with normal blood glucose(P <0.01)and the group with hyperglycemia and diabetes (P <0.05).Conclusion Patients with acute cerebral infarction associated with high FBG and high HbA1c had high hsCRP, and severe prognosis.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2008
Tipo del documento:
Article